Brandinium

Trademark search for:

RIGEN

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2005-09-29 — Application filed
  • 2005-10-04 — Application filed
  • 2006-04-03 — Assigned to examiner
  • 2006-04-07 — Priority action written
  • 2006-04-07 — Priority action e-mailed
  • 2006-10-03 — Teas change of correspondence received
  • 2006-10-03 — Teas change of correspondence received
  • 2006-10-03 — Office action issued
  • 2006-10-03 — Correspondence received in law office
  • 2006-10-12 — Teas/email correspondence entered
  • 2006-10-24 — Office action issued
  • 2006-10-26 — Approved for pub - principal register
  • 2006-10-26 — Amendment from applicant entered
  • 2006-10-26 — Correspondence received in law office
  • 2006-10-27 — Assigned to lie
  • 2006-10-31 — Law office publication review completed
  • 2006-11-29 — Notice of publication
  • 2006-12-19 — Extension of time to oppose received
  • 2006-12-19 — Published for opposition
  • 2007-03-19 — Opposition instituted no. 999999
  • 2007-07-02 — Application abandoned
  • 2007-07-02 — Application abandoned
  • 2007-07-02 — Opposition sustained no. 999999
  • 2007-07-02 — Final status recorded

Owner Information

Riley Genomics, Inc.
Oklahoma City , OK
Riley Genomics, Inc.
Oklahoma City , OK

Correspondent

Martin G. Ozinga Phillips McFall McCaffrey McVay & Murrah
Corporate Tower
13th Floor 101 N. Robinson Ave.
Oklahoma City, OK 73102

Filing Details

Filing Date:
2005-09-29
Status Date:
2007-07-02
Filing Year:
2005

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.